Vanderbilt Ingram Cancer Center Archives
Christine Lovly 2021 recipient of the ECOG-ACRIN Young Investigator Award
Jun. 9, 2021—Christine Lovly, MD, PhD, is the recipient of the 2021 ECOG-ACRIN Young Investigator Award, a major recognition of research excellence.
National Black Family Cancer Awareness Week is call to action
Jun. 9, 2021—National Black Family Cancer Awareness Week, June 17-23, aims to spur conversations followed by actions to make advancements in care more equitable.
Vanderbilt-Ingram Cancer Center calls for action to get cancer-preventing HPV vaccination back on track
May. 27, 2021—A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.
Vanderbilt researchers present new data on clinical trials at ASCO 2021
May. 26, 2021—Vanderbilt-Ingram Cancer Center researchers will present data on clinical trials involving targeted therapies, immunotherapies and drug combination synergies at the 2021 American Society of Clinical Oncology Annual Meeting, June 4-8. The meeting is a virtual event this year.
William and Frances Blot deed home to VUMC to benefit cancer patients
May. 20, 2021—Their condominium in The Westbury was at the heart of all that William and Frances Blot loved about Nashville — its proximity to Vanderbilt where he worked for two decades, its sidewalk that led to the greenspaces where they would watch the seasons change, and its residents who became more like friends than neighbors.
People at high genetic risk for colorectal cancer benefit more from lifestyle changes
May. 13, 2021—People with a high polygenic risk score for colorectal cancer could benefit more at preventing the disease by leading healthy lifestyles than those at lower genetic risk, according to a study by Vanderbilt researchers published in the April issue of The American Journal of Clinical Nutrition.
AACR second session to feature Vanderbilt researchers
May. 12, 2021—The second session of the American Association for Cancer Research (AACR) Annual meeting, May 17-21, features several researchers from Vanderbilt-Ingram Cancer Center.
New clinical guidance issued for people at increased cancer risk due to PALB2 gene variance
May. 11, 2021—The American College of Medical Genetics and Genomics (ACMG) has released important new clinical practice guidance for the surveillance and treatment of patients with a gene variant that puts them at increased risk for cancer.
IMPACT research grants to help underserved patients access clinical trials
May. 6, 2021—The Leukemia & Lymphoma Society (LLS) announced today the launch of IMPACT (Influential Medicine Providing Access to Clinical Trials) research grants to increase enrollment of individuals from underrepresented communities in clinical trials. Vanderbilt University Medical Center is leading one of the first three projects to receive IMPACT funding.
Grisanti receives VUMC Social Worker of the Year Award
Apr. 29, 2021—Lindsay Grisanti, LMSW, is the recipient of the Carolyn Edwards Social Worker of the Year Award at Vanderbilt University Medical Center.
Zheng named VICC associate director for Population Sciences Research
Apr. 21, 2021—Wei Zheng, MD, PhD, MPH, Anne Potter Wilson Professor of Medicine, has been named associate director for Population Sciences Research at Vanderbilt- Ingram Cancer Center (VICC).
New therapeutic strategy for leukemia syndrome
Apr. 20, 2021—Using primary cells from patients with chronic myelomonocytic leukemia, Vanderbilt researchers found synergistic inhibition of cell viability and proliferation, suggesting a new treatment strategy.
